CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to enhance early cancer detection using a tunable blue laser that excites a photosensitizer, improving the contrast between healthy and cancerous tissues. By employing advanced imaging technology, it seeks to provide a non-invasive diagnostic tool that can significantly reduce the burden of cancer thr…
In Europe there are 3 million new cancer cases per year.
According to the WHO the burden of cancer can be reduced by systematic and equitable implementation of evidence based strategies for cancer prevention, early detection and management of patients with cancer. 33% of the cancer burden could be reduced if detected early and treated adequately.
The WHO concludes that, early diagnosis of cancers could save the developed world an average of €40 billion per year on medical costs and €80 billion…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, Glasgow
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Poland, WARSZAWA
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
United Kingdom, Dundee
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
Netherlands, Amsterdam
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
